Literature DB >> 24782328

New candidate loci identified by array-CGH in a cohort of 100 children presenting with syndromic obesity.

Marie-Laure Vuillaume1, Sophie Naudion, Guillaume Banneau, Gwenaelle Diene, Audrey Cartault, Dorothée Cailley, Julie Bouron, Jérôme Toutain, Georges Bourrouillou, Adeline Vigouroux, Laurence Bouneau, Fabienne Nacka, Isabelle Kieffer, Benoit Arveiler, Anja Knoll-Gellida, Patrick J Babin, Eric Bieth, Béatrice Jouret, Sophie Julia, Pierre Sarda, David Geneviève, Laurence Faivre, Didier Lacombe, Pascal Barat, Maithé Tauber, Marie-Ange Delrue, Caroline Rooryck.   

Abstract

Syndromic obesity is defined by the association of obesity with one or more feature(s) including developmental delay, dysmorphic traits, and/or congenital malformations. Over 25 syndromic forms of obesity have been identified. However, most cases remain of unknown etiology. The aim of this study was to identify new candidate loci associated with syndromic obesity to find new candidate genes and to better understand molecular mechanisms involved in this pathology. We performed oligonucleotide microarray-based comparative genomic hybridization in a cohort of 100 children presenting with syndromic obesity of unknown etiology, after exhaustive clinical, biological, and molecular studies. Chromosomal copy number variations were detected in 42% of the children in our cohort, with 23% of patients with potentially pathogenic copy number variants. Our results support that chromosomal rearrangements are frequently associated with syndromic obesity with a variety of contributory genes having relevance to either obesity or developmental delay. A list of inherited or apparently de novo duplications and deletions including their enclosed genes and not previously linked to syndromic obesity was established. Proteins encoded by several of these genes are involved in lipid metabolism (ACOXL, MSMO1, MVD, and PDZK1) linked with nervous system function (BDH1 and LINGO2), neutral lipid storage (PLIN2), energy homeostasis and metabolic processes (CDH13, CNTNAP2, CPPED1, NDUFA4, PTGS2, and SOCS6).
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  CNV; array-CGH; chromosomal aberrations; copy number variations; deletion; developmental delay; duplication; intellectual disability; syndromic obesity

Mesh:

Year:  2014        PMID: 24782328     DOI: 10.1002/ajmg.a.36587

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  24 in total

1.  The effect of copy number variations in chromosome 16p on body weight in patients with intellectual disability.

Authors:  Fátima Gimeno-Ferrer; David Albuquerque; Carola Guzmán Luján; Goitzane Marcaida Benito; Cristina Torreira Banzas; Alfredo Repáraz-Andrade; Virginia Ballesteros Cogollos; Montserrat Aleu Pérez-Gramunt; Enrique Galán Gómez; Inés Quintela; Raquel Rodríguez-López
Journal:  J Hum Genet       Date:  2018-12-05       Impact factor: 3.172

2.  Two New Cases of 1p21.3 Deletions and an Unbalanced Translocation t(8;12) among Individuals with Syndromic Obesity.

Authors:  Carla S D'Angelo; Mauren F Moller Dos Santos; Luis G Alonso; Celia P Koiffmann
Journal:  Mol Syndromol       Date:  2015-01-28

3.  Genome-wide copy number variation analysis identifies novel candidate loci associated with pediatric obesity.

Authors:  Thanuja Selvanayagam; Susan Walker; Matthew J Gazzellone; Barbara Kellam; Cheryl Cytrynbaum; Dimitri J Stavropoulos; Ping Li; Catherine S Birken; Jill Hamilton; Rosanna Weksberg; Stephen W Scherer
Journal:  Eur J Hum Genet       Date:  2018-07-05       Impact factor: 4.246

4.  Polymorphic Inversions Underlie the Shared Genetic Susceptibility of Obesity-Related Diseases.

Authors:  Juan R González; Carlos Ruiz-Arenas; Alejandro Cáceres; Ignasi Morán; Marcos López-Sánchez; Lorena Alonso; Ignacio Tolosana; Marta Guindo-Martínez; Josep M Mercader; Tonu Esko; David Torrents; Josefa González; Luis A Pérez-Jurado
Journal:  Am J Hum Genet       Date:  2020-05-28       Impact factor: 11.025

5.  Activation of a nerve injury transcriptional signature in airway-innervating sensory neurons after lipopolysaccharide-induced lung inflammation.

Authors:  Melanie Maya Kaelberer; Ana Isabel Caceres; Sven-Eric Jordt
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-03-11       Impact factor: 5.464

6.  Common variants associated with changes in levels of circulating free fatty acids after administration of glucose-insulin-potassium (GIK) therapy in the IMMEDIATE trial.

Authors:  K L Ellis; Y Zhou; L Rodriguez-Murillo; J R Beshansky; E Ainehsazan; H P Selker; G S Huggins; L A Cupples; I Peter
Journal:  Pharmacogenomics J       Date:  2015-12-08       Impact factor: 3.550

7.  Neurodevelopmental phenotype associated with CHD8-SUPT16H duplication.

Authors:  Thomas Smol; Caroline Thuillier; Elise Boudry-Labis; Anne Dieux-Coeslier; Bénédicte Duban-Bedu; Roseline Caumes; Sonia Bouquillon; Sylvie Manouvrier-Hanu; Catherine Roche-Lestienne; Jamal Ghoumid
Journal:  Neurogenetics       Date:  2019-12-10       Impact factor: 2.660

8.  Estimation of non-null SNP effect size distributions enables the detection of enriched genes underlying complex traits.

Authors:  Wei Cheng; Sohini Ramachandran; Lorin Crawford
Journal:  PLoS Genet       Date:  2020-06-15       Impact factor: 5.917

9.  First genome-wide association study in an Australian aboriginal population provides insights into genetic risk factors for body mass index and type 2 diabetes.

Authors:  Denise Anderson; Heather J Cordell; Michaela Fakiola; Richard W Francis; Genevieve Syn; Elizabeth S H Scaman; Elizabeth Davis; Simon J Miles; Toby McLeay; Sarra E Jamieson; Jenefer M Blackwell
Journal:  PLoS One       Date:  2015-03-11       Impact factor: 3.240

10.  A recurrent deletion on chromosome 2q13 is associated with developmental delay and mild facial dysmorphisms.

Authors:  Eva Hladilkova; Tuva Barøy; Madeleine Fannemel; Vladimira Vallova; Doriana Misceo; Vesna Bryn; Iva Slamova; Sarka Prasilova; Petr Kuglik; Eirik Frengen
Journal:  Mol Cytogenet       Date:  2015-07-31       Impact factor: 2.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.